Clinical Trials Logo

Focal Seizures clinical trials

View clinical trials related to Focal Seizures.

Filter by:
  • None
  • Page 1

NCT ID: NCT03254680 Withdrawn - Epilepsy Clinical Trials

Turmeric as Treatment in Epilepsy

Start date: March 2018
Phase: N/A
Study type: Interventional

This is a single center open-label pilot clinical trial of patients 1-70 years of age with greater than 6 seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures. Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months. Patients and caregivers will be asked to keep a seizure diary logging all clinical events during the course of the study. Serum comprehensive metabolic panel, complete blood count with differential, and antiseizure medication levels, will be monitored at baseline, 1.5 months, and at the end of 3 months.

NCT ID: NCT02369471 Completed - Epilepsy Clinical Trials

A Study of GWP42006 in People With Focal Seizures - Part A

Start date: March 2015
Phase: Phase 2
Study type: Interventional

To evaluate the pharmacokinetics, safety and tolerability of GWP42006 compared with placebo, in the presence of other antiepileptic drugs (AEDs).

NCT ID: NCT02365610 Completed - Epilepsy Clinical Trials

A Study of GWP42006 in People With Focal Seizures - Part B

Start date: March 2016
Phase: Phase 2
Study type: Interventional

To investigate the potential antiepileptic effects of GWP42006 as add-on therapy in subjects with inadequately controlled focal seizures.